Rite Aid Corporation (NYSE:RAD) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.
Rite Aid Corporation (NYSE:RAD) gained 1.7 Percent and closed its previous trading session at $1.79. The stock traded with the average Volume of 30.19 Million at the end of last session.
Rite Aid Corporation (NYSE:RAD) has the Market Capitalization of 2.05 Billion. The Stock has its 52-week High of $8.77 and 52-Week Low of $1.38 and it touched its 52-week high on 01/13/17 and 52-Week Low on 11/09/17.
The company reported its last earnings Actual EPS of $-0.01/share. While, the analyst predicted that the company could provide an EPS of $-0.01/share.
Sell side analysts plays vital role in buying and selling a stock where 0 analysts rated Rite Aid Corporation (NYSE:RAD) as Buy, 0 analysts given Outperform signal, 2 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.77% where SMA50 and SMA200 are 0.95% and -41.15% respectively.
The company shows its Return on Assets (ROA) value of 0.8%. The Return on Equity (ROE) value stands at 14%. While it’s Return on Investment (ROI) value is 5.4%.
Rite Aid Corporation (NYSE:RAD) currently has a Weekly Volatility of 8.34% percent while its Monthly Volatility is at 7.64% percent. While talking about Performance of the Stock, Rite Aid Corporation currently has a Weekly performance of -17.13%, monthly performance percentage is 13.29 percent, Quarterly performance is -28.97 percent, 6 months performance shows a percent value of -49.29% and Yearly Performance is -77.96 percent.
Rite Aid Corporation is a retail drugstore chain in the United States serving customers in numerous states across the country and in the District of Columbia. It operates stores in the majority of the major U.S. metropolitan markets. The company operates in two business segments: the retail drug segment and the pharmacy benefit management segment.